REFERENCES
- Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BH, Toghill PJ. Familial Hibernian fever. Q J Med. 1982;51:469–80.
- McDermott MF, Aksentijevich I, Galon J, McDermott EM, Oqunkolade BW, Centola M, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syn-dromes. Cell. 1999;97:133–44.
- Hull KH, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, et al. The TNF receptor-associated periodic syndrome (TRAPS), emerging concepts of an autoinflammatory disorder. Medicine. 2002;81:349–68.
- Colburn N, Kastner D. Hereditary periodic fever. In: Hochberg MC, Silman AJ, Smolen JS, Weinbalatt ME, Weisman MH, editors. Rheumatology. 4th ed. Philadelphia: Elsevier; 2008. p. 1619–40.
- Ida H, Eguchi K. TNF receptor-associated periodic syndrome (TRAPS) in Japan: clinical characterization, pathogenesis, diag-nostic criteria, and treatment (in Japanese). Jpn J Clin Immunol. 2007;30(2):90–100.
- Tsukamoto H, Ueda N, Horiuchi T. Progress in classification and treatment for TNF receptor-associated periodic syndrome (in Japanese). Jpn J Clin Immunol. 2011;34(5):361–8.
- Lobito AA, Kimberley FC, Muppidi JR, Komorow H, Jackson AH, Hull KM, et al. Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutations in TNFR1-associated periodic fever syndrome (TRAPS). Blood. 2006;108:1320–7.
- Simon A, Park H, Maddipati R, Lobito AA, Bulua AC, Jackson AJ, et al. Concerted action of wild-type and mutant TNF recep-tors enhances inflammation in TNF receptor 1-associated periodic fever syndrome. Proc Natl Acad Sci USA. 2010;107(21):9801–6.
- Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH, et al. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further geneticheterogeneity of periodic fevers. Am J Hum Genet. 2001 ;69(2):301–14.
- Stojanov S, McDermott MF. The tumor necrosis factor receptor-associated periodic syndrome: current concepts. Expert Rev Mol Med. 2005;7:1–18.
- Pelagatti MA, Meini A, Caorsi R, Cattalini M, Federici S, Zulian F, et al. Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. Arthritis Rheum. 2011 ;63(4) : 1141–50.
- Horiuchi T, Tsukamoto H, Mitoma H, Miyagawa H, Tamimoto Y, Yoshizawa S, et al. Novel mutations in TNFRSF1A in patients with typical tumor necrosis factor receptor-associated periodic syndrome and with systemic lupus erythematosus in Japanese. Int J Mol Med. 2004;14:813–8.
- Takagi K, Kawaguchi Y, Fujikawa S, Otani T, Sugiura T, Hara M. Tumor necrosis factor receptor-associated periodic syndrome with a C3OR mutation in a Japanese Family. Mod Rheumatol. 2007;17:265–6.
- Kusuhara K, Nomura A, Nakao F, Hara T. Tumor necrosis factor receptor-associated periodic syndrome with a novel mutation in the TNFRSF1A gene in a Japanese family. Eur J Pediatr. 2004;163:30–2.
- Ida H, Kawasaki E, Miyashita T, Tanaka F, Kamachi M, Izumi Y, et al. A novel mutation (T61I) in the gene encoding tumor necrosis factor receptor superfamily 1A (TNFRSF1A) in a Jap-anese patients with tumor necrosis factor-associated with periodic syndrome (TRAPS) associated with systemic lupus erythemato-sus. Rheumatology (Oxford). 2004;43:1292–9.
- Manki A, Nishikomori R, Nakata-Hizume M, Kunitomi T, Takei S, Urakami T, et al. Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritis. Allergol Int. 2006;55:337–41.
- Nakamura M, Kobashi M, Tokura Y. A novel missense mutation in tumor necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) manifesting adult-onset Still disease-like skin eruptions: report of a case and review of literature. Br J Dermatol. 2009;161: 968–70.
- Nakamura M, Tokura Y. A novel missense mutation in tumor necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) with high serum interleukin (IL)-22. Eur J Dermatol. 2010;20(4):508–9.
- Kai M, Tamaki S, Nishikomori R, Takaoka Y, Ohara 0, Oshima K. A case of TNF receptor-associated periodic syndrome (in Japanese). Ryumachika (Rheumatology). 2011;45(4):456–60.
- Ohmori S, Hino R, Nakamura M, Tokura Y. Heparin serves as a natural stimulant of the inflammasome and exacerbates the symptoms of tumor necrosis factor receptor-associated periodic syndrome (TRAPS). J Dermatol Sci. 2012;66:82–4.
- Hull KM, Wong K, Wood GM, Chu WS, Kastner DL. Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction. Arthritis Rheum. 2002;46(8):2189–94.
- Tsuchiya-Suzuki A, Yamazaki M, Nakamura A, Yamazaki K, Agematsu K, Matsuda M, et al. Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol. 2009;36(8): 1671–6.
- Sasaki H, Heike T. Hyperimmunoglobulinemia D and periodic fever syndrome (in Japanese). Jpn J Clin Immunol. 2011;34(5):382–7.
- Sacré K, Brihaye B, Lidove 0, Papo T, Pocidalo MA, Cuisset L, et al. Dramatic improvement following interleukin lbeta block-ade in tumor necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-alpha therapy. J Rheumatol. 2008;35(2):357–8.